Feasibility of Group-based Acceptance and Commitment Therapy for Adolescents (AHEAD) With Functional Somatic Syndromes: A Pilot Study
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 21
- 主要终点
- Change in Short Form Health Survey-36 (SF36) (Assessment of an aggregate score measuring physical health)
研究概览
简要总结
Recurrent and impairing functional somatic syndromes (FSS) are common in adolescents. Despite a high need for care, empirically supported treatments are lacking for youth. The aim of the uncontrolled was to assess feasibility and treatment potential of group-based Acceptance and Commitment Therapy (ACT) in a generic treatment approach for adolescents with multiple FSS i.e. "ACT for Health in Adolescents" (AHEAD).
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 15 Years 至 19 Years（Child, Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Bodily Distress Syndrome, multi-organ type of at least 12 months' duration
- •Raised since early childhood in Denmark or born by Danish parents
- •Understand, speak and read Danish
- •Moderate or severe impairment
排除标准
- •Acute psychiatric disorder demanding other treatment, or if the patient is suicidal.
- •A lifetime diagnosis of psychosis, mania or depression with psychotic symptoms (ICD-10: F20-29, F30-31, F32.2, F33.3), serious cognitive deficits or developmental disorders such as mental retardation and autism (ICD-10: F70, F84)
- •Substance abuse of e.g. narcotics, alcohol or medication.
- •Pregnancy at time of inclusion
- •Not able to participate in group-based treatment, e.g. patients with severe ADHD (ICD-10: F90), severe social phobia (ICD-10: F40.1) or conduct disorder (ICD-10: F91)
研究组 & 干预措施
Group-based Acceptance and Commitment Therapy
Group-based Acceptance and Commitment Therapy (ACT) for adolescents presenting with multiple functional somatic syndromes.
干预措施: Acceptance and Commitment Therapy (Behavioral)
结局指标
主要结局
Change in Short Form Health Survey-36 (SF36) (Assessment of an aggregate score measuring physical health)
时间窗: At baseline (i.e. at clinical assessment), and at 2, 4, 5, and 8 months (corresponding to group start, 8th, 9th module and follow up meeting)
Questionnaire, patient rated. Physical health measured with aggregate scores of the scales PF (physical functioning), BP (bodily pain) and VT (vitality). Score range 15-65. Higher scores indicating a higher degree of self-rated physical health.
次要结局
- Change in Limitation index Questionnaire(At baseline (i.e. at clinical assessment), before psychiatric consultation (approximately 2 weeks after clinical assessment), and at 2, 3, 4, 5, and 8 months (corresponding to before therapy, after 4th, 8th, 9th module and at follow up meeting))
- Change in Whiteley 7(At baseline (i.e. at clinical assessment), and at 2, 4, 5, and 8 months (corresponding to group start, 8th, 9th module and follow up meeting))
- Change in SF-36 PCS(At baseline (i.e. at clinical assessment), and at 2, 4, 5, and 8 months (corresponding to group start, 8th, 9th module and follow up meeting))
- Change in Bodily Distress Syndrome checklist (BDS checklist)(At baseline (i.e. at clinical assessment), and at 2, 4, 5, and 8 months (corresponding to group start, 8th, 9th module and follow up meeting))
- Change in AFQ-Y8 (Avoidance and Fusion Questionnaire in Youth)(At baseline (i.e. at clinical assessment) and at 2, 3, 4, 5, and 8 months (corresponding to before therapy, after 4th, 8th, 9th module and at follow up meeting))
- Change in SCL-8 Questionnaire(At baseline (i.e. at clinical assessment), and at 2, 4, 5, and 8 months (corresponding to group start, 8th, 9th module and follow up meeting))
- Change in SF-36 MCS(At baseline (i.e. at clinical assessment), and at 2, 4, 5, and 8 months (corresponding to group start, 8th, 9th module and follow up meeting))
- Change in IPQ-R Illness Perceptions Questionnaire(At baseline (i.e. at clinical assessment) and at 2, 3, 4, 5, and 8 months (corresponding to before therapy, after 4th, 8th, 9th module and at follow up meeting))
- Change in BRIQ Behavioural Responses to Illness Questionnaire(At baseline (i.e. at clinical assessment) and at 2, 3, 4, 5, and 8 months (corresponding to before therapy, after 4th, 8th, 9th module and at follow up meeting))
- PGIC (Patient Global Impression of Change)(At 8 months corresponding to at follow up meeting)